Skip to main content
Top
Published in: International Journal of Clinical Oncology 4/2020

01-04-2020 | Gastrectomy | Original Article

Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy

Authors: Kentaro Hara, Toru Aoyama, Tsutomu Hayashi, Masato Nakazono, Shinsuke Nagasawa, Yota Shimoda, Yuta Kumazu, Masakatsu Numata, Takanobu Yamada, Hiroshi Tamagawa, Manabu Shiozawa, Soichiro Morinaga, Norio Yukawa, Yasushi Rino, Munetaka Masuda, Takashi Ogata, Takashi Oshima

Published in: International Journal of Clinical Oncology | Issue 4/2020

Login to get access

Abstract

Introduction

We retrospectively evaluated the blood coagulation activity using the D-dimer level in the early period after gastrectomy and investigated whether postoperative hypercoagulation affects tumor recurrence and long-term survival in gastric cancer patients.

Methods

The study involved 650 patients who underwent curative resection for gastric cancer at Kanagawa Cancer Center between July 2009 and July 2013. They were divided into a low-D-dimer group (LD group) and high-D-dimer group (HD group) according to the median D-dimer level on postoperative day (POD) 7. The risk factors for overall survival (OS) and relapse-free survival (RFS) were identified.

Results

Of the 448 enrolled patients, 218 were classified into the LD group and 230 into the HD group. The 5-year OS rates after surgery were 90.8% and 81.3% in the LD and HD groups, respectively (p < 0.001). The 5-year RFS rates after surgery were 89.9% and 76.1% in the LD and HD groups, respectively (p < 0.001). A high D-dimer level on POD 7 (≥ 4.9 μg/ml) was identified as an independent predictive factor for both the OS (hazard ratio [HR] 1.955, 95% confidence interval [CI] 1.158–3.303, p = 0.012) and RFS (HR 2.182, 95% CI 1.327–3.589, p = 0.002). Furthermore, hematological recurrence was significantly more frequent in the HD group than in the LD group (p = 0.014).

Conclusion

A high D-dimer level on POD 7 may predict tumor recurrence and the long-term survival in patients who undergo gastrectomy for locally advanced gastric cancer. Patients with an elevated postoperative D-dimer level need careful observation and diagnostic imaging to timely detect tumor recurrence.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–386CrossRef Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–386CrossRef
2.
go back to reference Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20CrossRef Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20CrossRef
3.
go back to reference Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820CrossRef Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820CrossRef
4.
go back to reference Tsuburaya A, Mizusawa J, Tanaka Y et al (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653–660CrossRef Tsuburaya A, Mizusawa J, Tanaka Y et al (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653–660CrossRef
5.
go back to reference Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. https://doi.org/10.1016/s0140-6736(18)32557-1 CrossRefPubMed Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. https://​doi.​org/​10.​1016/​s0140-6736(18)32557-1 CrossRefPubMed
6.
go back to reference Ay C, Dunkler D, Pirker R et al (2012) High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica 97:1158–1164CrossRef Ay C, Dunkler D, Pirker R et al (2012) High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica 97:1158–1164CrossRef
7.
go back to reference Wojtukiewicz MZ, Hempel D, Sierko E et al (2016) Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis. Cancer Metastasis Rev 35:213–233CrossRef Wojtukiewicz MZ, Hempel D, Sierko E et al (2016) Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis. Cancer Metastasis Rev 35:213–233CrossRef
8.
go back to reference Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185CrossRef Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185CrossRef
9.
go back to reference Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123–134CrossRef Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123–134CrossRef
10.
go back to reference Fukumoto K, Taniguchi T, Usami N et al (2015) Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer. Surg Today 45:63–67CrossRef Fukumoto K, Taniguchi T, Usami N et al (2015) Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer. Surg Today 45:63–67CrossRef
11.
go back to reference Kilic L, Yildiz I, Sen FK et al (2015) D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients. Cancer Biomark 15:405–411CrossRef Kilic L, Yildiz I, Sen FK et al (2015) D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients. Cancer Biomark 15:405–411CrossRef
12.
go back to reference Liu P, Zhu Y, Liu L (2015) Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma. Onco Targets Ther 8:1335–1340CrossRef Liu P, Zhu Y, Liu L (2015) Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma. Onco Targets Ther 8:1335–1340CrossRef
13.
go back to reference Xu L, He F, Wang H et al (2017) A high plasma D-dimer level predicts poor prognosis in gynecological tumors in East Asia area: a systematic review and meta-analysis. Oncotarget 8:51551–51558PubMedPubMedCentral Xu L, He F, Wang H et al (2017) A high plasma D-dimer level predicts poor prognosis in gynecological tumors in East Asia area: a systematic review and meta-analysis. Oncotarget 8:51551–51558PubMedPubMedCentral
14.
go back to reference Yu J, Li D, Lei D et al (2016) Tumor-specific D-dimer concentration ranges and influencing factors: a cross-sectional study. PLoS ONE 11:e0165390CrossRef Yu J, Li D, Lei D et al (2016) Tumor-specific D-dimer concentration ranges and influencing factors: a cross-sectional study. PLoS ONE 11:e0165390CrossRef
15.
go back to reference Diao D, Cheng Y, Song Y et al (2017) D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer. BMC Cancer 17:56CrossRef Diao D, Cheng Y, Song Y et al (2017) D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer. BMC Cancer 17:56CrossRef
16.
go back to reference Ay C, Vormittag R, Dunkler D et al (2009) D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 27:4124–4129CrossRef Ay C, Vormittag R, Dunkler D et al (2009) D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 27:4124–4129CrossRef
17.
go back to reference Diao D, Wang Z, Cheng Y et al (2014) D-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients. PLoS ONE 9:e101125CrossRef Diao D, Wang Z, Cheng Y et al (2014) D-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients. PLoS ONE 9:e101125CrossRef
18.
go back to reference Liu L, Zhang X, Yan B et al (2014) Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients. PLoS ONE 9:e90547CrossRef Liu L, Zhang X, Yan B et al (2014) Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients. PLoS ONE 9:e90547CrossRef
19.
go back to reference Kanda M, Tanaka C, Kobayashi D et al (2017) Proposal of the coagulation score as a predictor for short-term and long-term outcomes of patients with resectable gastric cancer. Ann Surg Oncol 24:502–509CrossRef Kanda M, Tanaka C, Kobayashi D et al (2017) Proposal of the coagulation score as a predictor for short-term and long-term outcomes of patients with resectable gastric cancer. Ann Surg Oncol 24:502–509CrossRef
20.
go back to reference Association JGC (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112 Association JGC (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112
21.
go back to reference Japanese Gastric Cancer A (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20:1–19CrossRef Japanese Gastric Cancer A (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20:1–19CrossRef
22.
go back to reference Yamada T, Hayashi T, Cho H et al (2012) Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery. Gastric Cancer 15:34–41CrossRef Yamada T, Hayashi T, Cho H et al (2012) Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery. Gastric Cancer 15:34–41CrossRef
23.
go back to reference Dindo D, Demartines N, Clavien P-A (2004) Classification of Surgical Complications. Ann Surg 240:205–213CrossRef Dindo D, Demartines N, Clavien P-A (2004) Classification of Surgical Complications. Ann Surg 240:205–213CrossRef
24.
go back to reference Tanizawa Y, Bando E, Kawamura T et al (2017) Prevalence of deep venous thrombosis detected by ultrasonography before surgery in patients with gastric cancer: a retrospective study of 1140 consecutive patients. Gastric Cancer 20:878–886CrossRef Tanizawa Y, Bando E, Kawamura T et al (2017) Prevalence of deep venous thrombosis detected by ultrasonography before surgery in patients with gastric cancer: a retrospective study of 1140 consecutive patients. Gastric Cancer 20:878–886CrossRef
25.
go back to reference Kodama J, Seki N, Fukushima C et al (2013) Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis. Mol Clin Oncol 1:737–744CrossRef Kodama J, Seki N, Fukushima C et al (2013) Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis. Mol Clin Oncol 1:737–744CrossRef
26.
go back to reference Tsuji K, Eguchi Y, Kodama M (1996) Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. J Am Coll Surg 183:230–238PubMed Tsuji K, Eguchi Y, Kodama M (1996) Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. J Am Coll Surg 183:230–238PubMed
27.
go back to reference Wang Z, Fu J, Diao D et al (2011) Plasma D-dimer level in the perioperative period in non-small-cell lung cancer. Thorac Cancer 2:207–212CrossRef Wang Z, Fu J, Diao D et al (2011) Plasma D-dimer level in the perioperative period in non-small-cell lung cancer. Thorac Cancer 2:207–212CrossRef
Metadata
Title
Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy
Authors
Kentaro Hara
Toru Aoyama
Tsutomu Hayashi
Masato Nakazono
Shinsuke Nagasawa
Yota Shimoda
Yuta Kumazu
Masakatsu Numata
Takanobu Yamada
Hiroshi Tamagawa
Manabu Shiozawa
Soichiro Morinaga
Norio Yukawa
Yasushi Rino
Munetaka Masuda
Takashi Ogata
Takashi Oshima
Publication date
01-04-2020
Publisher
Springer Singapore
Published in
International Journal of Clinical Oncology / Issue 4/2020
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-019-01603-x

Other articles of this Issue 4/2020

International Journal of Clinical Oncology 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine